NFX Logo
Get our weekly newsletter that 315K+ startup teams read
All NFX Content 422
Why NFX Invested in Cyclana Bio: A Bioplatform Building Physiologically Accurate Human Tissue Models
Post Image
NFX’s $325M Fund IV and the Turning Point
Post Image
Meet the 2026 NFX Fellows
Post Image
The AI Utopia Doesn’t Exist Without Bio
Post Image
Cybersecurity’s Future Belongs to Startups
Post Image
Why NFX Invested in F2: AI for Private Financial Market Investors
Post Image
Why NFX Invested in Koi Security: The Future of App-Layer Security, Scaling at Hyperspeed
Post Image
Pricing the AI Workforce: From Pilots to Real Revenue
Post Image
Why NFX Invested in Maisa: The Unlock the AI Workforce Needs
Post Image
The Seasons of Fundraising
Post Image
Why Israeli Founders Have a Key AI Advantage
Post Image
Women’s Health 2.0: Beyond Fertility
Post Image
The False-Positive Incumbent
Post Image
How AI Companies Will Build Real Defensibility
Post Image
Longevity Can Save America
Post Image
Voice AI is Working. Here’s Where It Wins First
Post Image
Why Don’t Billionaires Invest In Longevity?
Post Image
The Network Effects of Where You Build
Post Image
The Upgraded Go-to-Market Playbook 
Post Image
Longevity’s First Blockbuster
Post Image
What It Really Takes To Make AI Agents Work
Post Image
The Next 10 Years Will Be About the AI Agent Economy
Post Image
How “Venture Capital 3.0” Impacts Founders in the AI Age
Post Image
The Five Stages of AI Agent Evolution
Post Image
Load More Content